Skin cancer and sun protection knowledge in chronically immunosuppressed patients and patients with planned iatrogenic immunosuppression

Skin cancer and sun protection knowledge in chronically immunosuppressed patients and patients with planned iatrogenic immunosuppression - SCSK-IS

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032511

Enrollment

250

Registered

2023-08-17

Start date

2023-08-18

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C44

Interventions

Group 1: validated SCSK-Scale and 3 additional questions regarding skin cancer and immunosuppression

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: aktive drug-based immunosuppression after organ transplantation planned drug-based immunosuppression (waiting list patient before organ transplantation) who are able to give written informt consent who are able to independently fill out questionaires

Exclusion criteria

Exclusion criteria: Minors and those unable to give consent as well as patients who cannot answer the questionnaires independently are excluded

Design outcomes

Primary

Measure	Time frame
Skin cancer and sun knowledge in chronically immunosuppressed patients after organ transplantation and patients with planned iatrogenic immunosuppression according to the validated SCSK-Scale and a questionnaire regarding skin cancer and immunosuppression	—

Secondary

Measure	Time frame
Differences in skin cancer and sun protection knowledge according sociodemographic and medical parameters	—

Countries

Germany

Contacts

Public ContactAnke Lonsdorf

Universitäts-Hautklinik Heidelberg

anke.lonsdorf@med.uni-heidelberg.de+496221568511

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026